Registered entities
Sonoma Biotherapeutics, Inc.
Reg. No. 83-4500565United States
Social engagement
Social engagement: 18.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
22 investors on record; lead investors include Lyell Immunopharma, Arch Venture Partners, 8VC, Lifeforce Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 55% |
| Private equity | 2 | 9% |
| Accelerator & incubator | 1 | 5% |
| Bank & private debt | 2 | 9% |
| Other / undisclosed | 5 | 23% |
Hiring activity
Hires occasionally
2 roles tracked across 2 of the last 12 months
9 Jun 2026 · Director, Regulatory Affairs
29 Oct 2025 · Sr Manager, Quality Assurance - Cell Therapy · Seattle
Based on job postings tracked across public sources.
Recent activity
20 Apr 2026
Leadership hire
Board of Directors
6 Mar 2026
Event
Leerink Global Healthcare Conference